2-hydroxy-5-(methoxycarbonyl)benzenaminium chloride | 65885-07-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-hydroxy-5-(methoxycarbonyl)benzenaminium chloride
• 英文别名: 3-amino-4-hydroxy-benzoic acid methyl ester; hydrochloride；3-Amino-4-hydroxy-benzoesaeure-methylester; Hydrochlorid；Methyl 3-amino-4-hydroxybenzoate hydrochloride；methyl 3-amino-4-hydroxybenzoate;hydrochloride
• CAS: 65885-07-6
• 化学式: C₈H₉NO₃*ClH
• mdl: MFCD21364986
• 分子量: 203.625
• InChiKey: XTMWVLWAAVBHML-UHFFFAOYSA-N

物化性质

• 熔点：
  223 °C

计算性质

• 辛醇/水分配系数(LogP)：
  0.84
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  72.6
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-hydroxy-5-(methoxycarbonyl)benzenaminium chloride 在 sodium cyanoborohydride 、 1-羟基苯并三唑 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 21.0h， 生成 2-Nitro-11-oxo-10-(2,4,6-trimethoxy-benzyl)-10,11-dihydro-dibenzo[b,f][1,4]oxazepine-8-carboxylic acid methyl ester
  参考文献：
  名称：

  Solid-phase synthesis of dibenzoxazepinones

  摘要：

  Two novel solid-phase routes to the pharmaceutically relevant dibenzoxazepinone nucleus are described. In one, a key cyclisation step involves intramolecular phenolate displacement of an activated aryl fluoride. In the second, the tricyclic nucleus is prepared in solution prior to derivatisation on resin. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2003.09.037
• 作为产物：
  描述：

  甲醇 、 3-氨基-4-羟基苯甲酸 在 乙酰氯 作用下， 以99%的产率得到2-hydroxy-5-(methoxycarbonyl)benzenaminium chloride
  参考文献：
  名称：

  Synthetic Approaches to Amino Analogues of N-Acetylcolchinol

  摘要：

  A straightforward synthesis of aminodibenzoxepines, new analogues of N-acetyleolchinol, is reported by using two different strategies. The first strategy involves a Grignard addition, a biaryl Suzuki-Miyaura coupling, and a HF-mediated cyclodehydration as key steps. A second strategy, better adapted to the synthesis of analogues bearing a benzylic substituent, was designed by inverting the order of the Grignard addition and the biaryl coupling. This allowed the rapid and reliable production of a series of substituted aminodibenzoxepines. A chelate model was proposed to account for the diastereoselectivity observed in the Grignard addition step.

  DOI：

  10.1021/jo900632a

文献信息

• POLYESTER COMPOUND
  申请人：Ajinomoto Co., Inc.

  公开号：US20160024248A1

  公开（公告）日：2016-01-28

  Polyester compounds obtained by reaction of a compound represented by formula (1): (defined herein) with a compound represented by formula (2): (defined herein) exhibit high thermal resistance.

  通过将式（1）所代表的化合物与式（2）所代表的化合物发生反应所得到的聚酯化合物具有高热稳定性。
• POLYAMIDE COMPOUND
  申请人：Ajinomoto Co., Inc.

  公开号：US20160237215A1

  公开（公告）日：2016-08-18

  Polyamide compounds obtained by reacting a compound represented by formula (1): with a compound represented by formula (2): where the variables are described herein exhibit excellent heat resistance.

  通过将化学式（1）所代表的化合物与化学式（2）所代表的化合物反应而获得的聚酰胺化合物，在热阻方面表现出优异的性能。其中，变量的描述详见文中。
• Composition and device structure for iontophoresis
  申请人：HISAMITSU PHARMACEUTICAL CO. INC.

  公开号：EP1080731A2

  公开（公告）日：2001-03-07

  Device structure 100 for iontophoresis provides electrode 101 and electrically conductive layer 102. Electrically conductive layer 102 contains active ingredient D and basic water swelling methacrylate copolymer P1 and/or acidic water swelling methacrylate copolymer P2. Electrode 101 and electrically conductive layer 102 are placed into a hollow of backing 103 and electrode terminal 104 is connected to electrode 101 through backing 103. Adhesive layer 105 is set around backing 103, and liner 106 to be removed when using the device, is placed so as to cover the hollow of backing 103.

  用于离子透入的设备结构 100 包括电极 101 和导电层 102。导电层 102 含有活性成分 D 和碱性遇水膨胀甲基丙烯酸酯共聚物 P1 和/或酸性遇水膨胀甲基丙烯酸酯共聚物 P2。电极 101 和导电层 102 放入背衬 103 的中空部分，电极端子 104 通过背衬 103 与电极 101 连接。粘合剂层 105 镶在背衬 103 周围，衬垫 106 在使用设备时取下，以覆盖背衬 103 的中空部分。
• IONTOPHORESIS DEVICE
  申请人：HISAMITSU PHARMACEUTICAL CO. INC.

  公开号：EP1177813A1

  公开（公告）日：2002-02-06

  The present invention provides an iontophoresis device allowing effective and continuous absorption for a long period. The iontophoresis device comprises the first electrode structure (100a) and the second electrode structure (110a) each having a hydrophilic conductive layer (102a, 112a) containing active ingredient and an electrode member (101a, 111a), and a power supply (120a) having polarity inverting means for switching over a current direction between the two electrode structures, wherein at least one of the first and the second electrode structures contains chloride ions and before administration, a chloride-ion content (P mg) is within a range satisfying the following equation:1.0 × (I × T × 0.022) ≤ P    wherein T represents a polarity inverting time (min) until polarity is inverted after energization in a certain direction and I represents an average current (mA).

  本发明提供了一种可长期有效持续吸收的离子透入装置。该离子透入装置包括第一电极结构（100a）和第二电极结构（110a），每个电极结构都有一个含有活性成分的亲水性导电层（102a，112a）和一个电极部件（101a，111a），以及一个电源（120a），该电源具有极性反转装置，用于在两个电极结构之间切换电流方向，其中第一和第二电极结构中至少有一个含有氯离子，在给药前，氯离子含量（P mg）在满足下式的范围内：1.0 × (I × T × 0.022) ≤ P 其中，T 表示极性反转时间（分钟），直到按一定方向通电后极性反转为止，I 表示平均电流（毫安）。
• Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
  申请人：——

  公开号：US20030130306A1

  公开（公告）日：2003-07-10

  Compounds are provided which have the structure 1 wherein Q is C or N, X 1 is CH or N and, A, E, M, G, X 2 , X 3 , X 4 , R 1 , R 2 , R 2a , R 2b , R 2c , R 3 , Y, x, m, and n are as defined herein, which compounds are useful as antidiabetic, hypolipidemic, and antiobesity agents.

  提供的化合物具有如下结构 1 其中 Q 是 C 或 N，X 1 是 CH 或 N，以及 A、E、M、G、X 2 , X 3 , X 4 , R 1 , R 2 , R 2a , R 2b , R 2c , R 3 Y、x、m 和 n 如本文所定义，这些化合物可用作抗糖尿病、降血脂和抗肥胖药物。